ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/009/SRR9098249/SRR9098249_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/008/SRR9098248/SRR9098248_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/001/SRR9098241/SRR9098241_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/005/SRR9098245/SRR9098245_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/009/SRR9098229/SRR9098229_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/000/SRR9098230/SRR9098230_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/000/SRR9098240/SRR9098240_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/002/SRR9098242/SRR9098242_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/007/SRR9098247/SRR9098247_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/008/SRR9098228/SRR9098228_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/006/SRR9098246/SRR9098246_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/001/SRR9098241/SRR9098241_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/009/SRR9098239/SRR9098239_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/007/SRR9098237/SRR9098237_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/001/SRR9098251/SRR9098251_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/004/SRR9098244/SRR9098244_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/000/SRR9098240/SRR9098240_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/004/SRR9098234/SRR9098234_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/008/SRR9098238/SRR9098238_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/005/SRR9098235/SRR9098235_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/003/SRR9098243/SRR9098243_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/002/SRR9098242/SRR9098242_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/006/SRR9098236/SRR9098236_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/001/SRR9098231/SRR9098231_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/009/SRR9098239/SRR9098239_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/000/SRR9098230/SRR9098230_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/009/SRR9098249/SRR9098249_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/007/SRR9098237/SRR9098237_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/008/SRR9098238/SRR9098238_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/008/SRR9098248/SRR9098248_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/006/SRR9098236/SRR9098236_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/003/SRR9098233/SRR9098233_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/000/SRR9098250/SRR9098250_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/002/SRR9098232/SRR9098232_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/005/SRR9098245/SRR9098245_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/003/SRR9098233/SRR9098233_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/006/SRR9098246/SRR9098246_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/004/SRR9098244/SRR9098244_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/004/SRR9098234/SRR9098234_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/002/SRR9098232/SRR9098232_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/000/SRR9098250/SRR9098250_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/008/SRR9098228/SRR9098228_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/005/SRR9098235/SRR9098235_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/003/SRR9098243/SRR9098243_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/007/SRR9098247/SRR9098247_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/001/SRR9098231/SRR9098231_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/009/SRR9098229/SRR9098229_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR909/001/SRR9098251/SRR9098251_2.fastq.gzprimaryOK200GenomicsInstitute of Bioengineering and Nanotechnologyhttps://www.ebi.ac.uk/ena/browser/view/PRJNA543935In order to mitigate antibiotic resistance, a new strategy to increase antibiotic potency and reverse drug resistance is needed. Here, we leverage the translocation mechanism of an antimicrobial guanidinium-functionalized polycarbonate in combination with traditional antibiotics to afford a strong synergistic treatment for drug-resistant bacteria. This polymer-antibiotic combination approach reverses rifampicin resistance in A. baumannii demonstrating a 2.5×105 folds reduction in MIC. This approach also enables the repurposing of auranofin as antibiotic against multidrug-resistant (MDR) Gram-negative bacteria with a 500-fold MIC reduction. Finally, the in vivo efficacy of polymer-rifampicin combination is demonstrated in a MDR bacteremia mouse model. This combination approach lays foundational ground rules for a new class of antibiotic adjuvants capable of reversing drug resistance and enhancing potency of common antibiotics against MDR bacteria.xref:EuropePMC:PMC7503100ENAfalseAntibiotic/Macromolecule Combination Reverses Antibiotic Resistance and Promotes Synergy2023-05-192020-06-02PRJNA543935